Trial Profile
Phase II Study of High-Dose Topotecan, Cyclophosphamide and Melphalan for the Treatment of Multiple Myeloma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Melphalan (Primary) ; Topotecan (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 30 Dec 2009 New trial record